Search
Descriptor English: Dipyridamole
Descriptor Spanish: Dipiridamol
Descriptor dipiridamol
Scope note: Inhibidor de la fosfodiesterasa que bloquea la captación y el metabolismo de la adenosina por los eritrocitos y las células endoteliales vasculares. El dipiridamol también potencia la acción antiagregante de la prostaciclina. (AMA Drug Evaluations Annual, 1994, p752)
Descriptor Portuguese: Dipiridamol
Descriptor French: Dipyridamole
Entry term(s): Antistenocardin
Apo Dipyridamole
Apo-Dipyridamole
Cerebrovase
Cléridium
Curantil
Curantyl
Dipyramidole
Kurantil
Miosen
Novo Dipiradol
Novo-Dipiradol
Persantin
Persantine
Tree number(s): D03.383.742.175
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D004176
Scope note: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Phosphodiesterase Inhibitors
Platelet Aggregation Inhibitors
Vasodilator Agents
Registry Number: 64ALC7F90C
CAS Type 1 Name: Ethanol, 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-
Public MeSH Note: 66; was PERSANTIN 1963-65
History Note: 66; was PERSANTIN 1963-65
DeCS ID: 4235
Unique ID: D004176
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2017/05/24
Dipyridamole - Preferred
Concept UI M0006533
Scope note A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
Preferred term Dipyridamole
Entry term(s) Dipyramidole
Apo-Dipyridamole - Narrower
Concept UI M0485237
Preferred term Apo-Dipyridamole
Entry term(s) Apo Dipyridamole
Cerebrovase - Narrower
Concept UI M0485238
Preferred term Cerebrovase
Persantine - Narrower
Concept UI M0006534
Preferred term Persantine
Entry term(s) Persantin
Curantil - Narrower
Concept UI M0374377
Preferred term Curantil
Entry term(s) Curantyl
Kurantil
Miosen - Narrower
Concept UI M0485235
Preferred term Miosen
Novo-Dipiradol - Narrower
Concept UI M0485234
Preferred term Novo-Dipiradol
Entry term(s) Novo Dipiradol
Antistenocardin - Narrower
Concept UI M0374378
Preferred term Antistenocardin
Cléridium - Narrower
Concept UI M0485236
Preferred term Cléridium



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey